California Pharmacy Law Exam

💬 Patient Counseling and Education

What this topic covers

Subpart 2B (Educate Patients and Health Care Professionals) of the Content Outline effective June 1, 2022: the duty to consult, written patient information, nonprescription products and devices, and intern pharmacists. These are original practice notes, not documents of the California State Board of Pharmacy or PSI, based on law and FDA labeling in force on January 1, 2027; time limits, thresholds and quantities can change with each year's legislation. Nothing here is medical advice.

Duty to consult

Written information and patient rights

Drug Facts counseling

Devices and education

Intern pharmacists

Take the free test · full question bank and mock exams with a subscription

Sample questions (5)

1. Under 16 CCR section 1707.2, a pharmacist must provide oral consultation whenever the prescription drug:

  1. is a controlled substance on a federal schedule
  2. has a lower-cost generic equivalent available
  3. has not been dispensed to the patient before
  4. is being paid for under a third-party plan

16 CCR section 1707.2(a)(3) requires oral consultation “whenever the prescription drug has not previously been dispensed to a patient”. The regulation does not tie the duty to a controlled-substance schedule, to the availability of a generic equivalent, or to the payer, so none of those facts triggers consultation under section 1707.2(a).

2. Patient M.D. picks up a refill of the same drug, strength, dosage form and directions that Harbor Point Pharmacy has dispensed to her for years. She asks no questions, and the pharmacist has no concern about her therapy. Under 16 CCR section 1707.2, the pharmacist:

  1. may dispense the refill without oral consultation
  2. must consult orally, since each dispensing requires it
  3. must consult orally, but a technician may deliver it
  4. may dispense, but she must first sign a waiver

16 CCR section 1707.2(a) lists four triggers: a request, the pharmacist's professional judgment, a drug not previously dispensed, or a change in dosage form, strength or written directions. None applies to an unchanged refill. Where consultation is due, the duty rests on the pharmacist and not on a technician, and the regulation requires no signed waiver before an unchanged refill is dispensed.

3. Patient V.S. has taken lisinopril tablets from Cedar Ridge Pharmacy for a year. Today's new prescription is for the same drug in a higher strength, with the same written directions. Must the pharmacist provide oral consultation?

  1. No, because the drug itself was dispensed to her before
  2. Yes, because a year has passed since her first fill
  3. No, because the written directions have not changed
  4. Yes, because the strength differs from the prior fill

Under 16 CCR section 1707.2(a)(4), consultation is required whenever a drug not previously dispensed “in the same dosage form, strength or with the same written directions” is dispensed. A change in any one of the three is enough, so the earlier dispensing of the same drug and the unchanged directions do not excuse the pharmacist. The time elapsed since her first fill is not a trigger named in section 1707.2(a); the new strength is.

4. A pharmacist at Mission Oaks Pharmacy fills a prescription for patient L.P. for a drug previously dispensed to her as tablets. The new prescription is for the same drug and strength as an oral liquid, with the same directions. The pharmacist:

  1. may skip consultation, since the drug and strength match
  2. must consult orally, since the dosage form is new to her
  3. must consult orally when the prescriber requests it
  4. may give her a printed leaflet instead of consulting

16 CCR section 1707.2(a)(4) requires oral consultation when a prescription drug is dispensed in a dosage form not previously dispensed to the patient, even if the drug and strength are the same. Prescriber approval is not a condition of the duty. Written information is the required substitute only when the patient is not present, as section 1707.2(b) describes, and not when she is at the counter.

5. Under 16 CCR section 1707.2(d), when the pharmacist deems it warranted in professional judgment, oral consultation shall also include:

  1. the pharmacy's acquisition cost for the dispensed drug
  2. the pharmacist's own continuing education record
  3. the action to be taken in the event of a missed dose
  4. the National Drug Code of the dispensed product

16 CCR section 1707.2(d)(7) lists “action to be taken in the event of a missed dose” among the additional topics for consultation when the pharmacist deems it warranted. The same subdivision names the name and description of the drug, route, dosage form, refill information and contraindications. Acquisition cost, the pharmacist's education record, and the National Drug Code do not appear in section 1707.2(d).

Start free

California Pharmacy Law Exam · Topics · Exam guide · Sample questions